Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MEFLOQUINE Cause Progressive multifocal leukoencephalopathy? 50 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Progressive multifocal leukoencephalopathy have been filed in association with MEFLOQUINE (Mefloquine Hydrochloride). This represents 16.3% of all adverse event reports for MEFLOQUINE.

50
Reports of Progressive multifocal leukoencephalopathy with MEFLOQUINE
16.3%
of all MEFLOQUINE reports
28
Deaths
26
Hospitalizations

How Dangerous Is Progressive multifocal leukoencephalopathy From MEFLOQUINE?

Of the 50 reports, 28 (56.0%) resulted in death, 26 (52.0%) required hospitalization, and 8 (16.0%) were considered life-threatening.

Is Progressive multifocal leukoencephalopathy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MEFLOQUINE. However, 50 reports have been filed with the FAERS database.

What Other Side Effects Does MEFLOQUINE Cause?

Anxiety (67) Depression (53) Drug ineffective (45) Dizziness (41) Insomnia (35) Suicidal ideation (29) Headache (26) Paranoia (26) Tinnitus (26) Nausea (25)

What Other Drugs Cause Progressive multifocal leukoencephalopathy?

NATALIZUMAB (1,668) RITUXIMAB (1,647) CYCLOPHOSPHAMIDE (782) PREDNISONE (606) PREDNISOLONE (439) TACROLIMUS (438) METHOTREXATE (428) DOXORUBICIN (421) MYCOPHENOLATE MOFETIL (414) VINCRISTINE (376)

Which MEFLOQUINE Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?

MEFLOQUINE vs MEGESTROL MEFLOQUINE vs MEGLUMINE MEFLOQUINE vs MELATONIN MEFLOQUINE vs MELOXICAM MEFLOQUINE vs MELPERONE

Related Pages

MEFLOQUINE Full Profile All Progressive multifocal leukoencephalopathy Reports All Drugs Causing Progressive multifocal leukoencephalopathy MEFLOQUINE Demographics